Breckenridge Company Profile
✉ Email this page to a colleague
What is the competitive landscape for BRECKENRIDGE, and what generic and branded alternatives to BRECKENRIDGE drugs are available?
BRECKENRIDGE has forty-three approved drugs.
There are four tentative approvals on BRECKENRIDGE drugs.
Summary for Breckenridge
US Patents: | 0 |
Tradenames: | 42 |
Ingredients: | 42 |
NDAs: | 43 |
Patent Litigation for Breckenridge: | See patent lawsuits for Breckenridge |
PTAB Cases with Breckenridge as petitioner: | See PTAB cases with Breckenridge as petitioner |
Drugs and US Patents for Breckenridge
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Breckenridge | ENTECAVIR | entecavir | TABLET;ORAL | 208721-001 | Mar 15, 2018 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Breckenridge | TERIFLUNOMIDE | teriflunomide | TABLET;ORAL | 209583-001 | Sep 24, 2021 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Breckenridge Pharm | POLYETHYLENE GLYCOL 3350 | polyethylene glycol 3350 | FOR SOLUTION;ORAL | 077736-001 | May 26, 2006 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Paragraph IV (Patent) Challenges for BRECKENRIDGE drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Delayed-release Tablets | 20 mg | ➤ Subscribe | 2015-06-03 |
Similar Applicant Names
Here is a list of applicants with similar names.